2336 GMT - Iress's bulls at Wilsons expect the Australian financial-tech provider to spend the rest of its 2025 fiscal year increasingly focused on cost efficiencies following its decision to sell its superannuation business. Wilsons' analysts see the sale as a definitive pull by Iress on a key lever for near-term earnings momentum. Without a divestment, a sharp turnaround would have been needed, they write in a note. They tell clients that the proceeds won't be entirely spent on retiring debt and think that M&A activity is possible. Wilsons keeps an overweight rating and A$11.00 target price on the stock, which is up 0.9% at A$9.725. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
January 20, 2025 18:36 ET (23:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.